RT Journal Article
SR Electronic
T1 MAO inhibitors: Risks, benefits, and lore
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP 859
OP 882
DO 10.3949/ccjm.77a.09103
VO 77
IS 12
A1 Molly Wimbiscus
A1 Olga Kostenko
A1 Donald Malone
YR 2010
UL http://www.ccjm.org/content/77/12/859.abstract
AB Monoamine oxidase (MAO) inhibitors were the first antidepressants introduced, but their use has dwindled because of their reported side effects, their food and drug interactions, and the introduction of other classes of agents. However, interest in MAO inhibitors is reviving. Here, we discuss their use, risks, and benefits in clinical medicine.